 |
Moein
Moghimi
Professor, Faculty of Pharmaceutical Sciences, Copenhagen University |
Moein Moghimi is Professor of Biopharmacy at the Faculty of Pharmaceutical Sciences, Copenhagen University, Denmark. His research activities are focused on pharmaceutical nanotechnology and experimental nanomedicines. Key areas include design and surface engineering of nanoparticulate delivery vehicles and functional nanosystems for parenteral site-specific targeting and imaging modalities (splenotropic entities, lymphotropic agents and ‘phagocyte-resistant’ nanoparticles) as well as molecular toxicology of polymeric and particulate complexes.
Moein Moghimi has previously served as invited Theme Editor for three Theme Issues of Advanced Drug Delivery Reviews (Elsevier) (1995, 2000, and 2006) and one issue of Current Drug Delivery (Bentham) (2005). He is currently the Associate Editor of the Journal of Biomedical Nanotechnology (American Scientific publishers) and serves on the editorial/advisory board of the Journal of Liposome Research (Informa Healthcare), Nanomedicine-UK (Future Medicine), Current Patents in Drug Delivery and Formulation (Bentham), Current Drug Discovery Technologies (Bentham), International Journal of Clinical Research and Drug Development (Synconsys) and Multimedia Distributed Knowledge Network in Nanotechnology (Nanopolis™, France). In addition, he is a consultant to numerous pharmaceutical, biotechnology, health, and food industries as well as investment banks, management consultancy firms and other entrepreneurial enterprises world-wide.
In 1985, he graduated in biochemistry from The University of Manchester (UK) and in 1989 completed a PhD in liposome immunobiology at Charing Cross and Westminster Medical School (Imperial College, University of London, UK).